Santen Pharmaceutical Co (4536) Cash flow

0 Followers

Santen Pharmaceutical Co Cash Flow

JP:4536's free cash flow for Q2 2026 was ¥4.32B. For the 2026 fiscal year, JP:4536's free cash flow was decreased by ¥17.61B and operating cash flow was ¥5.85B. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 26	Mar 25	Mar 24	Mar 23
Operating Cash Flow	¥ 60.93B	¥ 43.50B	¥ 72.65B	¥ 37.15B	¥ 46.04B
Investing Cash Flow	¥ -8.22B	¥ -12.97B	¥ -6.14B	¥ -26.78B	¥ -35.17B
Financing Cash Flow	¥ -53.31B	¥ -49.35B	¥ -34.03B	¥ -37.22B	¥ 5.56B
End Cash Position	¥ 93.00B	¥ 80.88B	¥ 94.58B	¥ 57.90B	¥ 83.01B
Free Cash Flow	¥ 54.27B	¥ 36.66B	¥ 63.33B	¥ 19.87B	¥ 28.70B

Currency in JPY